Contrast absorption and pancreatic inflammation following experimental ERCP

Area of Science:

• Gastroenterology
• Radiology
• Pathology

Background:

• Intraductal injections are used for pancreatic imaging and interventions.
• Understanding the physiological effects of these injections is crucial for patient safety.
• Pancreatic inflammation can alter normal physiological processes.

Purpose of the Study:

• To investigate the effects of intraductal saline and contrast agents on the rat pancreas.
• To assess the impact of acute pancreatitis on the clearance of injected contrast agents.
• To evaluate the histological outcomes following pancreatic acinarization.

Main Methods:

• Rats underwent intraductal injection of saline or contrast agents (e.g., meglumine diatrizoate, metrizamide) into the pancreatic duct.
• Contrast agent clearance was monitored by measuring radioactivity (125I) in venous blood over time.
• Sodium taurocholate was used to induce acute pancreatitis in a subset of rats.
• Histological examination of pancreatic tissue was performed four days post-injection.

Main Results:

• In normal rats, injected contrast agents appeared rapidly in venous blood, peaking at 5 minutes.
• In rats with induced pancreatitis, the appearance of contrast agents in the blood was significantly retarded.
• Ninety-two percent of rats showed histological evidence of pancreatic atrophy or pancreatitis four days after injection, regardless of the agent used.

Conclusions:

• Intraductal injection of saline or contrast agents sufficient to cause acinarization can lead to pancreatic damage in rats.
• Acute pancreatitis impairs the clearance of intraductally injected contrast agents from the bloodstream.
• These findings highlight potential risks associated with intraductal pancreatic procedures, especially in inflamed pancreata.